Stock Movers: Novo Nordisk, Johnson & Johnson, and ServiceNow Updates

Novo Nordisk's Obesity Drug Approval

• 💊 Novo Nordisk received US approval for an oral pill version of its obesity drug Wegovy, a significant move to defend its market share against competitor Eli Lilly.
• 📈 This news led to shares soaring by as much as 11% in Copenhagen, marking the biggest single-day gain since August, despite the stock being down 41% year-to-date.

Johnson & Johnson's Talc Lawsuit Verdict

• ⚖️ Johnson & Johnson was ordered to pay approximately $1.56 billion to a Maryland woman who claimed the company's talc-based baby powder caused her asbestos-linked cancer.
• 📉 This verdict, the largest individual award in 15 years of litigation, follows previous setbacks for J&J related to over 70,000 lawsuits concerning its baby powder products.
• 📉 Shares of J&J experienced a decline in trading following the announcement.

ServiceNow's Largest Acquisition

• 🤝 ServiceNow announced a deal to acquire cybersecurity startup Armis for $7.75 billion, its largest acquisition to date.
• 💻 As an IT management company, ServiceNow aims to bolster its cybersecurity offerings with this acquisition, which is expected to close in the second half of 2026.
• 📉 ServiceNow shares fell about 1.3% in early trading following the acquisition news.

Market Performance and Trends

• 🚀 The S&P 500 reached a new record high, reflecting broad market optimism as the year concludes.
• 📈 Major indexes like the S&P 500 and NASDAQ have seen double-digit returns this year, exceeding both bull and bear expectations.
• 🌍 Despite geopolitical concerns and evolving economic outlooks, the market has shown resilience, ending the year with strong gains.